Back to Search Start Over

SHORT-TERM THALIDOMIDE INCORPORATED INTO DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION IMPROVES OUTCOMES IN COMPARISON WITH DOUBLE AUTOTRANSPLANTATION FOR MULTIPLE MYELOMA